Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat

Pathology Research and Practice

Volumn 210, Issue 6, 2014, Pages 357-362

  Yang, Jiaqing ^a   Song, Shilei ^a   Li, Jian ^a   Liang, Tao ^b  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin; Hippocampi; Neural injury; Neuroprotection

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CURCUMIN; DOPAMINE; NORADRENALIN; PHOSPHATIDYLINOSITOL 3 KINASE; ANTIPARKINSON AGENT; NEUROPROTECTIVE AGENT; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN HOMOGENATE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NONHUMAN; NORADRENALIN BRAIN LEVEL; OPEN FIELD TEST; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPATIAL MEMORY; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; CELL PROTECTION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; NERVE REGENERATION; PARKINSONIAN DISORDERS; PATHOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CURCUMIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; NOREPINEPHRINE; OXIDOPAMINE; PARKINSONIAN DISORDERS; PHOSPHATIDYLINOSITOL 3-KINASES; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKB; SIGNAL TRANSDUCTION;

EID: 84899477033     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.02.005     Document Type: Article

References (25)

1. Bird C.M., Burgess N. The hippocampus and memory: insights from spatial processing. Nat. Rev. Neurosci. 2008, 9(3):182-194.
2. Ruediger S., Spirig D., Donato F., Caroni P. Goal-oriented searching mediated by ventral hippocampus early in trial-and-error learning. Nat. Neurosci. 2012, 15:1563-1571.
3. Carlesimo G.A., Piras F., Assogna F., Pontieri F.E., Caltagirone C., Spalletta G. Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study. Neurology 2012, 78:1939-1945.
4. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50:711-719.
5. Joelving F.C., Billeskov R., Christensen J.R., West M., Pakkenberg B. Hippocampal neuron and glial cell numbers in Parkinson's disease-a stereological study. Hippocampus 2006, 16:826-833.
6. Costa C., Sgobio C., Siliquini S., Tozzi A., Tantucci M., Ghiglieri V., Di Filippo M., Pendolino V., de Iure A., Marti M., Morari M., Spillantini M.G., Latagliata E.C., Pascucci T., Puglisi-Allegra S., Gardoni F., Di Luca M., Picconi B., Calabresi P. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 2012, 135:1884-1899.
7. Calabresi P., Mercuri N.B., Di Filippo M. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. Brain 2009, 132:285-287.
8. Cohen-Cory S., Kidane A.H., Shirkey N.J., Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 2010, 70:271-288.
9. Park H., Poo M.M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 2013, 14:7-23.
10. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
11. Massa S.M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J.N., Nehama D., Rajadas J., Longo F.M. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J. Clin. Invest. 2010, 120:1774-1785.
12. Dai R., Xia Y., Mao L., Mei Y., Xue Y., Hu B. Involvement of PI3K/Akt pathway in the neuroprotective effect of Sonic hedgehog on cortical neurons under oxidative stress. J. Huazhong Univ. Sci. Technol. Med. Sci. 2012, 32:856-860.
13. Man H.Y., Wang Q., Lu W.Y., Ju W., Ahmadian G., Liu L., D'Souza S., Wong T.P., Taghibiglou C., Lu J., Becker L.E., Pei L., Liu F., Wymann M.P., MacDonald J.F., Wang Y.T. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron 2003, 38:611-624.
14. Li Q., Zhao D., Bezard E. Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature. Behav. Pharmacol. 2006, 17:403-410.
15. Xiong P., Chen X., Zhang N. Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease. Zhongguo Zhong Yao Za Zhi 2012, 37:686-691.
16. Mythri R.B., Bharath M.M. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr. Pharm. Des. 2012, 18:91-99.
17. Yallapu M.M., Ebeling M.C., Khan S., Sundram V., Chauhan N., Gupta B.K., Puumala S.E., Jaggi M., Chauhan S.C. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol. Cancer Ther. 2013, 12:1471-1480.
18. Li R., Zheng N., Liang T., He Q., Xu L. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. Brain Res. 2013, 1517:28-35.
19. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006, 1:848-858.
20. Wang Q.S., Ding S.L., Mao H.P., Cui Y.L., Qi X.J. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice. J. Ethnopharmacol. 2013, 148:603-609.
21. Jang D.P., Min H.K., Lee S.Y., Kim I.Y., Park H.W., Im Y.H., Lee S., Sim J., Kim Y.B., Paek S.H., Cho Z.H. Functional neuroimaging of the 6-OHDA lesion rat model of Parkinson's disease. Neurosci. Lett. 2012, 513:187-192.
22. Kulich S.M., Chu C.T. Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity. J. Biosci. 2003, 28:83-89.
23. Choi A.Y., Choi J.H., Lee J.Y., Yoon K.S., Choe W., Ha J., Yeo E.J., Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem. Int. 2010, 57:143-152.
24. Oguzturk H., Ciftci O., Aydin M., Timurkaan N., Beytur A., Yilmaz F. Ameliorative effects of curcumin against acute cadmium toxicity on male reproductive system in rats. Andrologia 2012, 44:243-249.
25. Mansouri Z., Sabetkasaei M., Moradi F., Masoudnia F., Ataie A. Curcumin has neuroprotection effect on homocysteine rat model of Parkinson. J. Mol. Neurosci. 2012, 47:234-242.